UniSa - IRIS Institutional Research Information System

PELLECCHIA, Maria Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.561
EU - Europa 2.719
AS - Asia 2.492
SA - Sud America 376
OC - Oceania 49
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.510
SG - Singapore 1.020
CN - Cina 730
IT - Italia 654
UA - Ucraina 517
RU - Federazione Russa 512
BR - Brasile 338
VN - Vietnam 274
IE - Irlanda 272
DE - Germania 247
SE - Svezia 173
TR - Turchia 164
KR - Corea 140
FI - Finlandia 120
HK - Hong Kong 60
GB - Regno Unito 49
IN - India 43
EE - Estonia 38
AT - Austria 32
AU - Australia 29
CZ - Repubblica Ceca 28
CA - Canada 27
NL - Olanda 27
NZ - Nuova Zelanda 20
FR - Francia 17
MX - Messico 14
AR - Argentina 11
IL - Israele 9
EC - Ecuador 8
JP - Giappone 8
PL - Polonia 7
VE - Venezuela 7
IQ - Iraq 6
PK - Pakistan 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
GR - Grecia 4
JM - Giamaica 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BE - Belgio 3
CL - Cile 3
ES - Italia 3
KE - Kenya 3
LU - Lussemburgo 3
MY - Malesia 3
NP - Nepal 3
AL - Albania 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
UY - Uruguay 1
Totale 12.216
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.422
Chandler 730
Princeton 707
Wilmington 661
Jacksonville 657
Singapore 337
Dong Ket 270
Dublin 262
Ashburn 259
Woodbridge 233
Houston 221
Nanjing 156
Beijing 154
Izmir 153
Moscow 143
Andover 141
Boardman 125
Pellezzano 109
Naples 104
Dearborn 93
Salerno 90
Hong Kong 56
Norwalk 56
Düsseldorf 55
Fairfield 54
Nanchang 49
Hebei 46
Shenyang 45
Changsha 44
Redwood City 41
Tallinn 38
Jiaxing 36
Pune 32
Mestre 27
Rome 27
The Dalles 26
Nuremberg 23
São Paulo 22
Brno 21
Dallas 21
Los Angeles 21
West Jordan 21
Tianjin 16
Washington 16
Belo Horizonte 14
Milan 14
San Diego 14
Amsterdam 13
Helsinki 13
Lecce 13
Seattle 13
Cambridge 11
Guangzhou 11
Auckland 10
Fort Worth 10
Lappeenranta 10
Pompei 10
Shanghai 10
Vienna 10
Kunming 9
San Francisco 9
Sydney 9
Wuhan 9
Brasília 8
Brisbane 8
Jinan 8
Perugia 8
Rio de Janeiro 8
Campinas 7
Carapicuíba 7
Hefei 7
Melbourne 7
Ribeirão Preto 7
Springfield 7
São José dos Campos 7
Assago 6
Bologna 6
Casoria 6
Fuzhou 6
Guarulhos 6
Montreal 6
Ottawa 6
Porto Alegre 6
Prineville 6
Rize 6
Council Bluffs 5
Curitiba 5
Frankfurt am Main 5
Marano di Napoli 5
Saint Petersburg 5
Santa Maria A Vico 5
Vietri Sul Mare 5
Atlanta 4
Clifton 4
Hangzhou 4
Mercato San Severino 4
Monza 4
Munich 4
New York 4
Padova 4
Totale 8.248
Salva come PNG Salva come JPEG
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 140
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 135
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 128
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 125
The natural history of multiple system atrophy: A prospective European cohort study 119
Brain anatomical substrates of mirror movements in Kallmann syndrome. 112
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 110
Increased bilirubin levels in de novo Parkinson's disease 109
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 107
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 104
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 104
Sindromi parkinsoniane 102
The alpha-synuclein gene in multiple system atrophy 100
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 99
The accuracy of the arginine growth hormone test in parkinsonism. 98
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 96
Gender and non motor fluctuations in Parkinson's disease: A prospective study 95
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 94
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 93
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 92
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 91
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 91
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 91
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 91
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 90
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 89
On the relationship between side of onset and cognition in Parkinson disease 89
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 89
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 88
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 88
A genome-wide association study in multiple system atrophy 87
The relevance of gender in Parkinson's disease: a review 85
Quitting smoking: An early non-motor feature of Parkinson's disease? 84
Early MRI findings in acquired hepatocerebral degeneration. 83
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 83
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 82
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 81
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 81
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 81
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 80
Mutant COQ2 in multiple-system atrophy. 78
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 77
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 77
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 77
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 77
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 76
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 75
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 75
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 75
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 75
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 75
A critique of the second consensus criteria for multiple system atrophy 75
Uric acid relates to dopamine transporter availability in Parkinson's disease. 74
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 74
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 74
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 74
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 74
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 74
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 73
The European Multiple System Atrophy-Study Group (EMSA-SG) 73
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 73
Parkinson’s disease and the spectrum of Lewy body disease 73
Postganglionic sudomotor denervation in patients with multiple system atrophy. 72
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 71
Evolution of mild cognitive impairment in Parkinson disease 71
Paradoxical response to apomorphine in a case of atypical parkinsonism 69
Evidenze di efficacia nella riabilitazione della malattia di Parkinson 69
Diagnostic agreement in patients with psychogenic movement disorders. 69
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 69
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 69
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 68
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 68
SNCA variants are associated with increased risk for multiple system atrophy 67
Safety and tolerability of growth-hormone therapy in multiple system atrophy 67
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 67
Resting brain networks in patients with Parkinson's disease and freezing of gait 67
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 67
Caratteristiche Cliniche 67
Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis 66
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 66
Neuropsychiatric disorders in Cushing's syndrome 66
Multiple system atrophy is distinguished from idiopathic Parkinson's disease bythe arginine growth hormone stimulation test 65
Drug induced oromandibular dystonia: A case related to prolonged use of cetirizine 65
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 64
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 64
Clinical presentation and treatment of Wilson's disease: a single-centreexperience 63
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 63
Is arginine test a reliable tool for differential diagnosis of multiple system atrophy? 63
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 63
Paroxysmal dystonia in Behçet's disease 62
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 61
UCHL-1 gene in multiple system atrophy: a haplotype tagging approach 61
Health-related quality of life in multiple system atrophy 61
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 61
Physical therapy in Parkinson's disease: an open long-term rehabilitation trial 61
Excitatory and inhibitory mechanisms in Wilson's disease: investigation withmagnetic motor cortex stimulation 61
Presentation, diagnosis, and management of multiple system atrophy in Europe:final analysis of the European multiple system atrophy registry 61
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 61
Early cues to detect atypical panthothenate kinase-associated neurodegeneration 61
Totale 8.026
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020252 0 0 0 0 0 0 0 0 0 0 222 30
2020/20211.167 10 95 106 1 154 80 131 14 120 3 131 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20252.578 147 35 65 158 159 318 418 342 507 303 126 0
Totale 12.819